Nuvalent, Inc. · 17 hours ago
Associate Director, Access & Reimbursement
United States
Full-time
Remote
Lead/Staff, Director/Executive
$185K/yr - $210K/yr
8+ years expNuvalent is an early-stage company focused on creating selective medicines for cancer patients. The Associate Director, Access & Reimbursement will play a crucial role in the Market Access team by providing field access support and education to healthcare professionals, aiming to maximize patient access to products.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Provides education to HCPs and their staff on payer-specific coverage criteria and documentation requirements to help address access and reimbursement barriers for prescriptions already in progress. Delivers guidance on access support, including processes, forms, payer-related coverage challenges, and the Nuvalent patient financial support programs
Educate HCP staff on patient support (PS) programs, resources, enrollment processes, and application updates so that they are informed on how to use our PS offerings & status of their patients
Proactively identify and help to resolve payer, account, and patient access barriers using data-driven insights, dashboards, and cross-functional collaboration
As the PS & payer landscape subject matter expert, coordinate with specialty pharmacy, PS operations, payer, market access, medical affairs, and other cross-functional colleagues to support patient access
Triage and resolve patient support related questions and access concerns escalated from field teams, ensuring timely and compliant resolution. Educate and inform regional field facing teams on PS programs, geographical payer nuances, access challenge trends, and program insights. Develop internal and external access tools & training materials
Develop patient access and reimbursement strategies with cross-functional teams, while monitoring regulatory, payer & industry trends, to proactively & compliantly address access challenges
Support oversight of patient support programs (financial assistance & non-commercial specialty pharmacy); ensuring accountability for positive customer impact & excellence. Coordinate regularly with PS operations teams on patient case updates and escalate as required
Qualification
Required
Bachelor's degree is required
8+ years of biopharma experience, including 3+ years of oncology field reimbursement manager (FRM) / or access reimbursement manager (ARM) experience with established relationships at major oncology centers across the country
Extensive experience in oral / specialty oncology access, rare disease launch, program implementation, and payer navigation
Demonstrated excellence in customer engagement
Previous experience supporting HCP staff through complex reimbursement barriers, prior authorizations, appeals, and providing education
Knowledge of all national health insurers (commercial & government) including billing/coding
Highly organized, team player, excellent communicator, problem solver, and presenter
Able to work effectively & autonomously through ambiguity
All activities must comply with HIPAA, OIG, FDA regulations, and Nuvalent policies. This is a non-promotional role
Preferred
Previous experience in a clinical role, NSCLC, Patient Services program oversight, & vendor management preferred
Prior Authorization Certified Specialist preferred
Willingness to travel domestically up to 20% (customer engagements, internal & vendor meetings)
Benefits
Medical, dental, and vision insurance
401(k) retirement savings plan
Generous paid time off (including a summer and winter company shutdown)
Company
Nuvalent, Inc.
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.82BKey Investors
Bain Capital Life SciencesDeerfield
2025-11-18Post Ipo Secondary· $500M
2024-09-16Post Ipo Equity· $575M
2023-10-16Post Ipo Equity· $300M
Leadership Team
James Porter
CEO
Alexandra Balcom
Chief Financial Officer
Recent News
MarketScreener
2025-12-16
Company data provided by crunchbase